Tag: antidepressant withdrawal
A new study promotes the use of a standardized approach to antidepressant tapering.
Paroxetine, SNRIs, and MAOIs were associated with the highest risk of withdrawal, as was long duration of use and whether the person experienced withdrawal in the past.
Researchers suggest that antidepressant withdrawal can be a possible precipitant of suicide.
The problems related to the use of antidepressants cannot be solved by an oversimplified psychiatry brainwashed by the pharmaceutical industry.
Mark Horowitz and David Taylor provide advice on how to tell the difference between antidepressant withdrawal and depression relapse.
Supportive patient-practitioner relationships are crucial to the successful discontinuation of psychiatric medication.
Do we take enough account of total drug exposure time when devising antidepressant tapering strategies?
Leading researchers point out that a new antidepressant study in NEJM failed to account for withdrawal symptoms, casting doubt on the results.
In this podcast, we hear from the renowned clinician and researcher Dr. Giovanni Fava about his latest book entitled “Discontinuing Antidepressant Medications”.
New guidance on how to taper and discontinue from psychiatric drugs from leading researchers Mark Horowitz and David Taylor.
A new study investigates how antidepressant withdrawal effects often get confounded with depression relapse in clinical trials.
Jim van Os and Peter Groot discuss their paper: “Successful Use of Tapering Strips for Hyperbolic Reduction of Antidepressant Dose: A Cohort Study” published in the journal Therapeutic Advances in Psychopharmacology.
Psychiatrists have made hundreds of millions of people dependent on psychiatric drugs and yet have done virtually nothing to find out how to help the patients come off them again.
Researchers find a lack of current literature on safe, effective ways to manage antidepressant withdrawal and make suggestions for future research.
Protracted Withdrawal Syndrome characterized by long-term adverse experiences after coming off of antidepressants.
A new study looks at how online communities provide information and support for patients experiencing psychiatric drug withdrawal.
Patient advocates join with researchers and service users to present first-hand experiences of antidepressant withdrawal.
“My life was very, very good.” That’s how Michael sums up how things were for him—prior to his suffering from devastating withdrawal effects after discontinuing GlaxoSmithKline’s blockbuster drug Paxil.
Our new discussion series aims to explore what we do and don’t know about safe withdrawal from antidepressants, antipsychotics, benzodiazepines and stimulants.
That is the truth about withdrawal syndrome: It’s like a 50-50 chance that you’re going to have a problem. If you’re in the unlucky half, you’re gonna be really unlucky.
Medically-induced harm—affecting tens of millions of people worldwide—has taken the field decades to take seriously.